Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

Nearly 1 in 2 Americans are Now Victims of This Heartless Marketing Ploy

Nearly 1 in 2 Americans are Now Victims of This Heartless Marketing Ploy

Story at-a-glance

  • The off-label use of the dangerous cancer drug Avastin for macular degeneration appears to be based on one study, which showed Avastin worked just as well as Lucentis—a licensed but more expensive eye drug. Meanwhile, numerous studies exist demonstrating the treatment potential of astaxanthin for this eye disorder. Astaxanthin may in fact be one of the most powerful nutrients ever discovered for eye health, and it costs pennies on the dollar compared to either drug.

WARNING!

This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.

Top

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Service.